Blue Jet Healthcare Ltd. operates as a pharmaceutical company. It engages in manufacturing molecules used in pharmaceutical and healthcare products. It operates through the following segments: Integrated contrast media intermediate manufacturer, Saccharin & it’s salts, Niche pharmaceutical intermediates & API and CDMO-CMO. The firm supplies intermediates to GE Healthcare, Guerbet and Bracco, and sweeteners to Colgate Palmolive (India) Limited and Unilever. The company was founded by B. L. Arora in 1968 and is headquartered in Thane, India.
BLUE JET HEALTHCARE LTD financial statements, including revenue, expenses, and profit: The total revenue of BLUEJET for the last quarter is 3.55 B INR, and it's 4.20% higher compared to the previous quarter. The net income of Q1 25 is 911.70 M INR.
BLUE JET HEALTHCARE LTD dividends overview: BLUEJET dividends are paid annually. The last dividend per share was 1.00 INR. As of today, Dividend Yield (TTM)% is 0.13%.
BLUE JET HEALTHCARE LTD earnings per share and revenue: BLUEJET earnings per share for the last quarter are 5.30 INR whereas the estimation was 6.25 INR which accounts for -15.27% surprise. Company revenue for the same period amounts to 3.55 B INR despite the estimated figure of 3.39 B INR. Also watch annual changes over time to get a bigger picture of BLUEJET earnings per share and revenue dynamics.
BLUE JET HEALTHCARE LTD revenue breakdown overview: BLUE JET HEALTHCARE LTD revenue for the last year amounted to 10.30 B INR, the most of which — 4.80 B INR — came from its highest performing source at the moment, Contrast Media, the year earlier bringing 5.07 B INR. The greatest contribution to the revenue figure was made by Norway — last year it brought BLUE JET HEALTHCARE LTD 4.02 B INR, and the year before that — 4.57 B INR.
Potential 50% Upside with Entry Price 725 Target Price 1075, Timeframe 6-12 Months
Comments
Post a Comment